SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001103021-22-000069
Filing Date
2022-03-22
Accepted
2022-03-22 17:14:17
Documents
1
Period of Report
2022-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164798364262984.html 4  
1 FORM 4 wf-form4_164798364262984.xml 4 15415
  Complete submission text file 0001103021-22-000069.txt   18083
Mailing Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612
Business Address 4131 PARKLAKE AVENUE SUITE 225 RALEIGH NC 27612 919 582 9050
BIODELIVERY SCIENCES INTERNATIONAL INC (Issuer) CIK: 0001103021 (see all company filings)

IRS No.: 352089858 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344 GRAND CAYMAN E9 KY1-1108
Business Address C/O 20 GENESIS CLOSE ANSBACHER HOUSE, 2ND FLOOR, PO BOX 1344 GRAND CAYMAN E9 KY1-1108 212-808-2460
Broadfin Healthcare Master Fund Ltd (Reporting) CIK: 0001511900 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 22760651

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2460
Broadfin Capital, LLC (Reporting) CIK: 0001511901 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 22760652

Mailing Address C/O BROADFIN CAPITAL, LLC 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
KOTLER KEVIN (Reporting) CIK: 0001601692 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31361 | Film No.: 22760653